Morello by Mediasurface has been chosen by AstraZeneca, one of the world’s leading pharmaceutical companies, as the sole platform of choice for its new Global Web Content Management System, in one of the largest content management projects ever undertaken.
Mediasurface were short-listed along with four other competitors after a lengthy pre-qualification process. The tender involved working closely with AstraZeneca to produce a 300 point ‘proof of concept’ as well as successfully delivering a pilot project that built a handful of websites to demonstrate the functional and usability benefits of Morello. Morello will replace AstraZeneca’s two existing bespoke WCM systems and a handful of agency based WCM systems as part of their global
e-service integration strategy (ESI).
Lawrence Flynn, CEO of Mediasurface said, “We are delighted that Mediasurface has been selected to partner AstraZeneca on this massive global project. It illustrates that our goal of combining an intuitive, business focused interface with enterprise strength technology is a real winning formula.”
Kay Wesley, Global Director - eMarketing for AstraZeneca said, “Morello offered the best total solution by meeting our key business criteria and new business innovation requirements in a way that some more established Enterprise Content Management (ECM) players could not. By combining a genuine focus on empowering the business user with intuitive features such as Instant Site (that allows us to rapidly deploy new enterprise websites in a controlled and compliant manner) Morello will help AstraZeneca maintain our industry lead in the online arena.”
The depth of the project is significant. AstraZeneca have over 250 content managed sites worldwide, which are a mixture of corporate and country sites, product and therapy sites, community initiatives and charitable causes, with varying numbers of authors and levels of traffic. The ESI programme is a complete integration led by sales and marketing, and wholly supported by IS. An integral part of this project was giving AstraZeneca’s e-Marketers and business users control of the web sites that they managed and were measured on.
Morello will enable AstraZeneca’s eMarketing team to create a de-centralised editorial community that delivers:
• A friendly, easy to use WCM system designed from the e-marketers perspective which empowers the user community to create and manage their websites
• A very powerful multi stage workflow management
• Wide support for foreign languages including Chinese and Japanese from both a content presentation and an editorial contribution perspective
• A flexible and scaleable approach to handle a wide variety of rich content including movies, PDF’s and flash content
• A flexible modern architecture based on common standards
• The ability to support thousands of editors
Other key requirements of Mediasurface were the ability to provide 24/7 global support, locally to the European, Asian, Australian and American regions and the ability to integrate into AstraZeneca’s larger Global Sales and Marketing Information Systems initiative including integration with AstraZeneca’s Siebel CRM solution.
“Morello has enabled us to complete our programme of rationalisation, bringing together our previous disparate systems under one, global technology that will enable seamless online relationships and a better experience for our customers and stakeholders. We will gain associated benefits from a cost, control and consolidation perspective and created a new global standard for our websites”, continued Wesley.
International Chamber of Commerce and Finastra bring trade funding marketplace pilot to Ecuador ICC TRADECOMM – designed to unlock the global $1...View article
Solution to facilitate faster analysis and decision making for investment managers. To enhance its global asset management clients’ decision-mak...View article
Profile Software, the international financial solutions provider, announced today the operational use of the omni-channel digital banking platform int...View article